Event Overview

The 39th Annual General Meeting (AGM) of Novyra Pharmachem Limited was held on Thursday, June 25, 2026, from 11:00 AM to 11:30 AM IST through video conferencing/other audio-visual means (VC/OAVM). The meeting was conducted in compliance with MCA Circulars (General Circular Nos. 14/2020, 17/2020, 20/2020, 22/2020, 02/2021, 10/2021, 19/2021, 02/2022, 10/2022, 09/2023, 09/2024, 03/2025) and SEBI Circulars (dated 5th January 2023, 13th May 2022, 15th January 2021, and 12th May 2020).

Meeting Conduct and Attendance

Mr. Anilkumar Amreliya, Director of the Company, chaired the meeting. Ms. Anisha Shyamsukha, Company Secretary, confirmed quorum presence and introduced directors and panelists. The company availed services of National Securities Depository Limited (NSDL) for conducting the meeting through video conferencing and handling remote e-voting and e-voting during the AGM.

Remote e-voting was available from Monday, June 22, 2026, at 9:00 AM until Wednesday, June 24, 2026, at 5:00 PM. Members who hadn't voted earlier could vote electronically during the meeting and up to 15 minutes after conclusion. Mrs. Rupal Patel, Practicing Company Secretary, was appointed as Scrutinizer to oversee the voting process.

Business Transacted

The following resolutions were presented and voted upon:

1. Ordinary Resolution: Consideration and Adoption of the Audited Financial Statements for the financial year ended March 31, 2026, along with Reports of the Board of Directors and Auditors. The audit report contained no qualifications, reservations, or adverse remarks.

2. Ordinary Resolution: Re-appointment of Mr. Sandeep Agarwal (DIN: 00688647) as Director, who retired by rotation and offered himself for re-appointment.

3. Special Resolution: Consideration and approval of the Scheme of Capital Reduction of the Company.

4. Special Resolution: Regularization of Appointment of Mr. Anilkumar Amreliya (DIN: 11339148) as Executive Director.

5. Special Resolution: Appointment of Mr. Anilkumar Amreliya (DIN: 11339148) as Managing Director.

Shareholder Engagement and Disclosure

No shareholder queries were raised during the meeting. The notice of the 39th AGM along with audited financial statements for FY ended March 31, 2026, and Director's Report were emailed to shareholders whose email addresses were registered with the company or RTA or their Depository Participants as of June 18, 2026. These documents were also hosted on the company's website (www.bansisonstea.in), BSE, and NSDL.

Outcome and Next Steps

The results of voting will be announced within 48 hours of the meeting's conclusion and displayed on the company's website, NSDL, and stock exchanges. The meeting concluded at 11:30 AM IST.

#Tags: #NovyraPharmachem #AGM #CapitalReduction #SEBIDisclosure #RegulatoryCompliance